Are Skin Boosters, Profhilo and Polynucleotides Safe During Pregnancy?

Elective skin-booster, Profhilo and polynucleotide injections are best postponed during pregnancy. Direct reproductive safety evidence is inadequate, and a familiar moisturising ingredient does not clear an injectable treatment. Breastfeeding also needs a product-specific review: some instructions explicitly advise against use. Terms such as hydrating, regenerative or natural describe a treatment's marketing or proposed effect, not a pregnancy safety result.

In this guide: the treatment types · what research establishes · breastfeeding labels.

Skin boosters, Profhilo, PN and PDRN are not one product #

Skin booster is a broad treatment description, not a single ingredient or standard formula. It may refer to an injectable hyaluronic-acid preparation or another product offered for skin quality and hydration. Ask what is actually in the syringe.

Profhilo is a product family associated with injectable hyaluronic acid. Versions within a family may have different compositions, intended effects and instructions. Do not assume that information for one version applies to another product with a related name.

Polynucleotides (PN) and polydeoxyribonucleotide (PDRN) are related terms used around nucleic-acid-derived preparations, but products and research contexts vary. A shared story about regeneration does not make every preparation clinically equivalent.

Some cosmetic serums also use PDRN-related terminology. Those are not automatically injectable products, and should not be used that way. The ingredient family, the finished formula and the route all need to be identified before an assessment can mean anything.

Are skin boosters and polynucleotides safe during pregnancy? What the evidence can answer #

We need pregnancy-specific information about the finished injectable product, not just evidence that a treatment improves a cosmetic outcome. Research in other adults may help describe effectiveness and ordinary adverse effects, but it cannot establish fetal safety.

A systematic review of aesthetic polynucleotides found a small, heterogeneous evidence base and called for better-quality studies. Its focus was cosmetic effectiveness; it does not provide pregnancy or breastfeeding clearance.

The distinction is crucial. A study reporting improved texture is answering whether participants' skin changed, not whether an exposure is appropriate during pregnancy. We should not turn the absence of reported pregnancy harm in an ordinary cosmetic study into a claim that pregnant participants were tested.

Our practical recommendation is to defer elective injections. That is a measured response to inadequate direct evidence, not proof that every past treatment caused harm. If a product is being considered for a medical reason, that indication requires a clinician's separate assessment.

Why hyaluronic acid's skincare verdict cannot be copied across #

Hyaluronic acid and sodium hyaluronate are familiar moisturising ingredients, and ordinary topical skincare can have a reassuring pregnancy assessment. An injectable product introduces a different exposure and procedural context.

For example, the manufacturer's Australian-hosted Profhilo instructions identify a medical device intended for intradermal use. The formulation and intended tissue placement are not the same as smoothing a serum over intact skin.

It is therefore misleading to say, “Your body already makes HA, so the injection is pregnancy-safe.” A naturally occurring molecule does not establish the suitability of every manufactured preparation or administration route.

Nor does a topical product's green ingredient badge assess sterility, injection injury, allergy or management of complications. Our hyaluronic-acid skincare guide intentionally covers ordinary cosmetics, not treatment clearance.

Breastfeeding and the importance of exact product instructions #

Pregnancy and breastfeeding differ, but some products restrict both. The linked Profhilo Structura instructions explicitly say not to use the product in pregnant or breastfeeding women.

That leaflet is hosted by the Australian manufacturer site and carries its own revision information. It is evidence of a restriction for that identifiable product, not proof that every product marketed as Profhilo has the same leaflet in every country.

Ask the clinic for the current local instructions for the exact preparation it proposes. An article, a distributor's reassurance or a generic “HA is local” explanation should not override those instructions.

For injectable polynucleotides, do not assume the absence of a familiar restriction means compatibility has been established. A clinician still needs product-specific evidence and information about your situation. A pause in feeding does not itself resolve these questions.

How to read a regenerative treatment claim #

Words such as salmon DNA, bioremodelling, tissue support or skin regeneration can sound scientific without answering the decision you face. Ask what substance is used, how it is prepared and which clinical study applies to that product.

The source material may matter for allergy assessment, but origin is not an all-purpose safety verdict. Natural does not mean sterile, non-allergenic or tested in pregnancy. Synthetic does not automatically mean dangerous either.

Be careful when a clinic moves between PN, PDRN and HA as if they were interchangeable. It should be able to explain the actual preparation and intended use in straightforward language, rather than leaning on a broad trend name.

Also ask whether the evidence concerns a cosmetic goal, a separate medical indication or a different route. Findings from wound-care research or laboratory experiments cannot be imported unchanged into an elective facial injection recommendation.

Treatment families compared #

Description	What it may involve	What a responsible assessment checks
HA skin booster	An injectable hyaluronic-acid preparation	Exact formulation, label, intended use and reproductive data
Profhilo product family	Specific HA-based injectable devices	The precise version and current local instructions
PN / PDRN injections	Nucleic-acid-derived preparations with differing specifications	Finished product, route, evidence and allergy considerations
Mesotherapy cocktail	A combination of substances	Every component and the evidence for the combination
Topical HA or PDRN skincare	Ordinary cosmetic application to skin	Its own complete formula and labelled use, not injection suitability

A short ingredient list in a treatment brochure is not enough. A medical product also has specifications, manufacturing requirements and instructions that are not captured by a cosmetic INCI comparison.

Needles, anaesthetic and combination treatments #

An injection carries questions beyond the headline active. The clinician needs to assess the treatment site, skin health, medicines and previous reactions. Any numbing preparation or additional medicine requires its own review.

A treatment bundled with microneedling, RF or a peel is not automatically covered by an injection-only explanation. Each procedure can alter the context, and evidence for separate components does not necessarily establish safety of the combination.

Do not purchase these preparations to inject at home. Do not use an ordinary serum as a cheaper substitute for a sterile injectable product. A legitimate assessment is not a set of instructions for doing the treatment yourself.

Tell the clinician about pregnancy or breastfeeding before a booking is confirmed. If the discussion immediately becomes about concealing that status or finding a clinic that will ignore a restriction, stop and seek independent medical advice.

Ordinary hydration options while you wait #

If the main concern is dry, tight-looking skin, everyday skincare may provide enough comfort while elective treatment is deferred. It will not reproduce the tissue placement or cosmetic effect of an injection, and it should not be advertised as doing so.

These two examples are ordinary cosmetics for intact skin, not injectable preparations or immediate aftercare for freshly punctured skin.

Ingredient lists and MamaSkin scores checked 27 September 2026. Scores are out of 100 and apply to the formula shown, not every regional version. Match your packaging. These examples are for everyday use on intact skin, not injections or immediate procedure aftercare.

One includes niacinamide alongside sodium hyaluronate; the other combines several hyaluronic-acid forms with panthenol. Their scores concern the complete cosmetic ingredient lists. Neither tells us whether a skin-booster appointment is appropriate.

Choose the texture you already tolerate, and avoid adding several new products simply because a treatment is postponed. If redness or a skin condition is driving the decision, assessment of that condition may be more helpful than a hydrating package.

What if you had injections before discovering pregnancy? #

Ask the clinic for the product name and version, batch information, date, treated areas and all medicines used. Your maternity clinician can then assess the actual exposure instead of a broad category such as regenerative injections.

Postponing future elective treatment does not mean that a past injection caused harm. Avoid panic-driven “detox” products, unplanned dissolving treatments or another procedure intended to cancel the first one.

If the product is unfamiliar, ask for its patient information rather than relying on a marketing page. Similar names may refer to different substances or regional versions. A clear record is useful even when you feel well.

If a complication is suspected, seek treatment promptly. Pregnancy or breastfeeding is important information for the treating clinician, not a reason to leave a significant problem untreated.

Warning signs and follow-up #

Severe or unusual pain, rapidly changing skin colour or vision changes after a facial injection needs immediate medical assessment. FDA filler guidance describes vascular complications for fillers; do not assume another facial injectable makes concerning symptoms irrelevant.

Increasing redness, heat, fever, drainage or persistent concerning lumps also deserves clinical review. Do not puncture a lump, apply strong acids or improvise treatment because an online discussion calls swelling normal.

Ask before treatment who provides follow-up and what happens outside clinic hours. A promise that reactions are always mild is not a useful plan for the person who needs help.

Questions for a future consultation #

• What exact product, version and route are proposed?
• What does its current local leaflet say about pregnancy and breastfeeding?
• Does the research concern this finished preparation or only a related ingredient?
• Is the goal cosmetic, and what benefit would be lost by waiting?
• Which other products or procedures are included?
• How are allergies and complications assessed?
• Can I have written information and time to decide?

A credible answer should acknowledge what is not known. You should not be asked to accept a reassuring ingredient story in place of product-specific evidence.

Related reading and sources #

• Lip and facial fillers
• Microneedling
• RF microneedling
• Topical hyaluronic acid
• MamaSkin methodology
• Check ordinary cosmetic ingredients

The sources above distinguish cosmetic-effectiveness research, manufacturer instructions and procedure warnings. This guide is informational, not medical advice. Formulations, local permissions and leaflets change; a qualified clinician should assess the exact treatment rather than transferring a topical ingredient verdict to an injection.

Editorial note: This is an informational evidence summary and has not been independently medically reviewed.